Ckim Pharma LLP - pharma in Namchi, Sikkim, India. FY 2026 financials & compliance.
LLPIN AAI-2659 Incorporated 13 January 2017 ROC Kolkata HQ Namchi, Sikkim, India
Active Limited Liability Partnership pharma
Data last updated
Revenue · FY 2023
₹14.59 Lakh
▲ 32% YoY
Net loss · FY 2023
₹31.74 Lakh
Net margin -217.5%
EBITDA · FY 2023
-₹11.66 Lakh
EBITDA margin -79.9%
Contribution obligation
₹1 Cr
As per LLP agreement
LLP age
9 yrs
Est. 2017
Designated partners
4
As per MCA filings
Active GSTINs
2
GST registered
Last financials
Mar 2025
Balance sheet date

About Ckim Pharma LLP

Data last updated:

Ckim Pharma LLP is a limited liability partnership (LLP) based in Namchi, Sikkim, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 January 2017 and has been in existence for over 9 years.

The LLP is registered with the Registrar of Companies (ROC), Kolkata, under LLPIN AAI-2659. Its GSTIN is 11AALFC9867E1ZB (Sikkim). The LLP holds 2 GST registrations, all of them active.

The LLP has a total obligation of contribution of ₹1 Cr. It is led by designated partners including Shankar Agarwal and Hemant Amrish Parikh.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Namchi Bazar Namchi, Sikkim, India – 737126.

As per the financials filed for FY 2023, the LLP reported a revenue of ₹14.59 Lakh, a growth of 32% compared to the previous year. For the same year it recorded a net loss of ₹31.74 Lakh (net margin -217.5%) and EBITDA of -₹11.66 Lakh (EBITDA margin -79.9%). Revenue has grown at a compounded annual rate (CAGR) of 277% over three years and 81% over five years.

Company Details of Ckim Pharma LLP
LLPIN AAI-2659
Incorporation Date 13 January 2017
Total Obligation of Contribution ₹1 Cr
ROC Kolkata
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Namchi Bazar Namchi, Sikkim, India – 737126
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Ckim Pharma LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Ckim Pharma LLP report

Financials, compliance, directors, charges, ownership and filings for Ckim Pharma LLP in one report.

Financials from FY 2017 Directors & ownership Charges & compliance

Financials of Ckim Pharma LLP FY 2025 filings available

Ckim Pharma LLP reported revenue of ₹14.59 Lakh (up 32% YoY) for FY 2023.

Revenue · FY 2023
₹14.59 Lakh ▲ 32%
Net loss · FY 2023
₹31.74 Lakh margin -217.5%
EBITDA · FY 2023
-₹11.66 Lakh margin -79.9%

Compounded Annual Growth Rate (CAGR) of Ckim Pharma LLP

Revenue CAGR growth
1 year
▲ 32%
3 years · compounded
▲ 277%
5 years · compounded
▲ 81%

Revenue has grown at a compounded annual rate (CAGR) of 81% over five years, including 32% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Ckim Pharma LLP

Statement of Account and SolvencyFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Income and Expenditure
Turnover••••••••••••••••••••
Other Income••••••••••••••••••••
Total Income••••••••••••••••••••
Purchases and Direct Costs••••••••••••••••••••
Personnel Expenses••••••••••••••••••••
Administrative Expenses••••••••••••••••••••
Interest••••••••••••••••••••
Depreciation••••••••••••••••••••
Total Expenses••••••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax••••••••••••••••••••
Profit After Tax-₹31.74 Lakh••••••••••••••••
Profit Transferred to Partners••••••••••••••••••••
Assets and Liabilities
Partners' Contribution••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Secured Loans••••••••••••••••••••
Unsecured Loans••••••••••••••••••••
Trade Payables••••••••••••••••••••
Other Liabilities and Provisions••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Loans and Advances••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Ckim Pharma LLP

Statement of Account and SolvencyFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
Net Profit Margin-217.5%••••••••••••••••
Return on Partners' Funds••••••••••••••••••••
Return on Assets••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Debt to Partners' Funds••••••••••••••••••••
Interest Coverage••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Turnover Growth••••••••••••••••••••
Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Ckim Pharma are in the company report.

Premium access

Financial statements from FY 2017

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Designated Partners of Ckim Pharma LLP

Ckim Pharma has 4 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Shankar AgarwalDesignated Partner13 Jan 20179 Years 8 MonthsCurrent
Hemant Amrish ParikhDesignated Partner14 Aug 20206 Years 1 MonthsCurrent
Girish BhattDesignated Partner14 Aug 20206 Years 1 MonthsCurrent
Mahabir Agarwal PrasadDesignated Partner13 Jan 20179 Years 8 MonthsCurrent

Ownership and Shareholding of Ckim Pharma LLP

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Ckim Pharma LLP

Ckim Pharma LLP does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Ckim Pharma LLP

Employment history and EPFO contributions of people linked to Ckim Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Ckim Pharma LLP

Ckim Pharma LLP has 5 designated partner changes on record since 2017: 4 appointments and 1 cessation. The latest: Girish Bhatt was appointed as Designated Partner on 14 Aug 2020.

AGM
Ckim Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Ckim Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Appointed
Girish Bhatt was appointed as Designated Partner.
Appointed
Hemant Amrish Parikh was appointed as Designated Partner.
Ceased
Harsh Kumar Doshi ceased to be Designated Partner.
Appointed
Mahabir Agarwal Prasad was appointed as Designated Partner.
Appointed
Shankar Agarwal was appointed as Designated Partner.
Incorporation
13 Jan 2017
Ckim Pharma Llp was registered on 13 Jan 2017 with Roc Kolkata & aged 9 years 8 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Ckim Pharma LLP

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Ckim Pharma LLP

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Ckim Pharma LLP

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Ckim Pharma LLP

Ckim Pharma has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
11AALFC9867E1ZBSikkimActive01 Jul 2017
24AALFC9867E1Z4GujaratActive08 Jan 2021
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Ckim Pharma LLP

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ckim Pharma LLP

Ckim Pharma is an active limited liability partnership based in Namchi, Sikkim, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 13 January 2017 (9+ years old) and is registered under LLPIN AAI-2659.

Ckim Pharma reported revenue of ₹14.59 Lakh for FY 2023 (up 32% YoY).

Ckim Pharma has 4 current designated partners:

Ckim Pharma reported a net loss of ₹31.74 Lakh (net margin -217.5%) and EBITDA of -₹11.66 Lakh (EBITDA margin -79.9%) for FY 2023, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Ckim Pharma is 277% over three years and 81% over five years. In the latest year (FY 2023) revenue rose 32%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Ckim Pharma is 11AALFC9867E1ZB, registered in Sikkim. The LLP has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AALFC9867E1Z4 (Gujarat).

The LLPIN (Limited Liability Partnership Identification Number) of Ckim Pharma is AAI-2659. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Ckim Pharma was incorporated on 13 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kolkata.

Girish Bhatt was appointed as Designated Partner on 14 Aug 2020. Hemant Amrish Parikh was appointed as Designated Partner on 14 Aug 2020. Harsh Kumar Doshi ceased to be Designated Partner on 11 Jul 2020. Ckim Pharma has 5 designated partner changes on record in total.

The registered office of Ckim Pharma is at Namchi Bazar Namchi, Sikkim, India – 737126.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available